Daniel is a UK and European Patent Attorney with experience in a wide range of IP matters in the life sciences. He advises clients in relation to biotech, pharmaceutical and medical device patents in a divers range of fields including formulation, immunotherapeutic, antibody and assay technologies. Daniel's practice includes UK and European prosecution, drafting, oppositions, portfolio management and foreign prosecution work.